Life Science & Technology Weekly 153 – Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Life Science, Technology
GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Life Science
Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio Life Science
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan Life Science
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Life Science
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China Life Science
BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor Life Science
Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year Life Science
Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province Life Science
